Please use this identifier to cite or link to this item:
Title: Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
Austin Authors: Gordon, Sally F;Virah Sawmy, Elise;Duckworth, Eleanor;Wolthuizen, Michelle;Clothier, Hazel J;Chea, Malinda;Tenneti, Naveen;Blow, Ngaree;Buttery, Jim P;de Luca, Joseph;Korman, Tony M;Barnes, Sara;Slade, Charlotte;Maggs, Callum;Giles, Michelle L;Teh, Benjamin W;Aboltins, Craig;Langan, Katherine M;Van Diemen, Annaliese;Crawford, Nigel W
Affiliation: Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Australia..
SAEFVIC, Murdoch Childrens Research Institute (MCRI), Melbourne, Australia..
Centre for Antibiotic Allergy and Research
Monash Infectious Diseases, Monash Health, Melbourne, Australia..
Vaccine Safety and Evaluation, COVID-19 Vaccination Program, Victorian Department of Health, Melbourne, Australia..
Department of Monash Lung, Sleep, Allergy and Immunology, Monash Health, Melbourne, Australia..
Department of Medicine, Monash University, Melbourne, Australia..
Department of Allergy and Clinical Immunology, Melbourne Health, Melbourne, Australia..
Department of Infectious Diseases, Barwon Health, Geelong, Australia..
Infectious Diseases Unit, Alfred Health, Melbourne, Australia..
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia..
Department of Infectious Diseases, Northern Health, Epping, Victoria, Australia..
Northern Health Clinical School, the University of Melbourne, Victoria, Australia..
Department of Infectious Diseases, Sunshine Hospital, Western Health, Melbourne, Australia..
Infectious Diseases
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia..
Issue Date: 30-Nov-2022 2022
Publication information: Human Vaccines & Immunotherapeutics 2022; 18(5): 2052701
Abstract: The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with complex vaccine safety questions, including those who experience adverse events following immunization (AEFI) after COVID-19 vaccines. VicSIS provides individual vaccination recommendations, allergy testing, vaccine challenges, and vaccination under supervision. VicSIS initially comprised of eight adult COVID-19 specialist vaccination clinics, subsequently, expanding to better support pediatric patients as the Australian vaccine roll-out extended to adolescents and children. Since their establishment to September 2021, the inaugural VicSIS clinics received a total of 26,401 referrals and reviewed 6,079 patients. Consults were initially predominantly for pre-vaccination reviews, later predominantly becoming post-vaccination AEFI reviews as the program progressed. Regardless of the type of consult, the most common consult outcome was a recommendation for routine vaccination (73% and 55% of consult outcomes respectively). VicSIS is an integral component of the COVID-19 vaccination program and supports confidence in COVID-19 vaccine safety by providing consistent advice across the state. VicSIS aims to strengthen the health system through the pandemic, bolstering specialist immunization services beyond COVID-19 vaccines, including training the next generation of vaccinology experts.
DOI: 10.1080/21645515.2022.2052701
ORCID: 0000-0003-0213-5470
PubMed URL: 35471988
PubMed URL:
Type: Journal Article
Subjects: COVID-19
immunisation service
vaccine allergy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Oct 1, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.